-
May.282024NEWS
HanAll Biopharma Signs Licensing Agreement with Turn Biotechnologies to Develop Novel Treatments for Eye and Ear Diseases
HanAll Biopharma Signs Licensing Agreement with Turn Biotechnologies to Develop Novel Treatments for..
-
May.072024NEWS
HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease
HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELO..
-
Apr.302024NEWS
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business
-
Apr.222024NEWS
HanAll Biopharma awards 2024 National Industry Awards for Research and Development Excellence
HanAll Biopharma awards 2024 National Industry Awards for Research and Development Excellence
-
Mar.212024NEWS
HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update
HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update
-
Mar.182024NEWS
HanAll Biopharma Opens Applications for 2024 Pharmaceutical Industry Fellowship Program Targeting Indonesian Physicians
HanAll Biopharma Opens Applications for 2024 Pharmaceutical Industry Fellowship Program Targeting In..